The Independent's journalism is supported by our readers. When you purchase through links on our site, we may earn commission.
'Chemical surgery' performed for first time on human embryos
Researchers removed the blood disorder beta-thalassemia
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists have carried out "chemical surgery" on human embryos to successfully remove a disease for the first time.
Researchers at Sun Yat-sen University in China used a technique called base editing to reprogramme a fault in a single base in our genetic code.
The experiments were carried out in laboratory-made embryos to remove the disease beta-thalassemia, an inherited blood disorder which can cause weakness, fatigue and lead to abnormal blood clots.
In the study, published in the journal Springer, the authors wrote: “β-Thalassemia is a global health issue, caused by mutations in the HBB gene.
“Among these mutations, HBB −28 (A>G) mutations is one of the three most common mutations in China and Southeast Asia patients with β-thalassemia.
“Correcting this mutation in human embryos may prevent the disease being passed onto future generations and cure anemia.”
The team edited one of the “fundamental building blocks of DNA” - the four bases adenine, cytosine, guanine and thymine (A, C, G and T), the BBC reported.
Combinations of these four bases essentially instruct how the human body works.
The blood disorder beta-thelassemia is caused by a change to a single base in the genetic code.
Using base editing, the researchers changed a G to an A to remove the blood disorder.
Base editing, pioneered by Harvard University Professor David Liu, is a new genome editing technology that allows the irreversible modification of genes within organisms.
He described the process as “chemical surgery”.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments